權識國際(00381.HK)與廣東企確通訂立戰略合作協定
權識國際(00381.HK)公布,公司與廣東企確通就共同推動資料確權技術與實體經濟融合,探索區塊鏈與元宇宙的創新應用場景相關事項訂立戰略合作協定書,合作協議期限為1年。
公司指,將與廣東企確通將基於BSN聯盟鏈技術,聯合開發資料確權平臺,為中小微企業提供資料存證、資產數位化及合規交易服務,優先應用於公司未來元宇宙生態專案。廣東企確通負責技術實施與本土化服務落地,公司提供國際資本對接及跨境合規支援,共同拓展粵港澳大灣區及東南亞市場。公司將開放元宇宙大會、AOM財富論壇等資源,協助廣東企確通技術成果國際化展示,而廣東企確通將引入政府數位化轉型政策支持,助力公司拓展內地市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.